Axsome Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $27M | 224k | 121.45 |
| 2025-03-31 | $35M | 302k | 116.63 |
| 2024-12-31 | $18M | 218k | 84.61 |
| 2024-09-30 | $33M | 363k | 89.87 |
| 2024-06-30 | $32M | 401k | 80.50 |
| 2024-03-31 | $23M | 292k | 79.80 |
| 2023-12-31 | $19M | 241k | 79.59 |
| 2023-09-30 | $14M | 195k | 69.89 |
| 2023-06-30 | $10M | 140k | 71.86 |
| 2023-03-31 | $17M | 269k | 61.68 |
| 2022-12-31 | $22M | 286k | 77.13 |
| 2022-06-30 | $15M | 377k | 38.30 |
| 2022-03-31 | $2.4M | 58k | 41.39 |
| 2021-12-31 | $3.0M | 80k | 37.76 |
| 2021-09-30 | $1.4M | 44k | 32.94 |
| 2021-03-31 | $8.1M | 143k | 56.62 |
| 2020-12-31 | $16M | 198k | 81.47 |
| 2020-09-30 | $24M | 331k | 71.25 |
| 2020-06-30 | $34M | 416k | 82.28 |
| 2019-12-31 | $21M | 204k | 103.36 |
| 2019-09-30 | $612k | 30k | 20.25 |
| 2019-06-30 | $566k | 22k | 25.74 |
| 2019-03-31 | $968k | 68k | 14.22 |
| 2017-12-31 | $238k | 43k | 5.60 |
| 2017-06-30 | $372k | 68k | 5.50 |
| 2017-03-31 | $121k | 31k | 3.91 |
| 2016-06-30 | $135k | 18k | 7.56 |
| 2015-12-31 | $226k | 24k | 9.25 |